A new report has projected the European medical cannabis market to reach $4.2bn by 2027, growing at a GACR of 17.1% from 2020.
The report by Business Market Insights, a market research platform that provides subscription service for industry and company reports, has projected the European cannabis market to reach (US) $4.2bn ($4,217.6m) by 2027 from $1,241.7m in 2019.
Growth of the European cannabis market
Providing an overview of the growth rate during the forecast period of 2021 to 2027, the report gives insights by segments based on end user and demography, along with an analysis of critical aspects such as impacting factors and the competitive landscape. Other segments include by product type, which is broken down into further segments, such as flowers and concentrate, and by application, incuding medical, pain management, neurological health management and mental health management.
With the growing use of medical cannabis across Europe, the Business Market Insight report examines micro-markets and sheds light on the impact of technology upgrades on the performance of the market.
It cites some major key players as Aphria, Aurora Cannabis, Cannabis Science, Canopy Growth Corporation and Medical Marijuana, and evaluates trends observed in the parent market, along with the macro-economic indicators, prevailing factors, and market appeal with regard to different segments, predicting the influence of different industry aspects on the Europe Cannabis market segments and regions.
Additionally, the report provides insights on key player’s positions against the regional landscape and conducts Strengths, Weaknesses, Opportunities, and Threats (SWOT) analysis, as well as analysis of market size, share, overall earnings, gross revenue, and profit margins.
The research focuses on mining out valuable data on investment pockets, growth opportunities, and major market vendors.
[activecampaign form=31]
